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Condom failure in South Africa
To the Editor: It was with great interest that we read the recent 
editorial by Dr Khumalo1 in which she expressed concern 
regarding potential condom failure in Africa. The issue of 
condom failure is certainly important and we were most 
alarmed by the lack of prevalence data on condom failure in 
South Africa. In her literature search Dr Khumalo did not find 
any research on the prevalence of condom failure in Africa 
aside from that in pregnant women. 
We have been conducting HIV/AIDS behavioural 
surveillance research at a large public health clinic that provides 
sexually transmitted infection (STI) services in Cape Town 
and have collected data that can help shed light on this urgent 
problem. In anonymous behavioural surveys collected from  
1 729 men and 470 women receiving STI services we have 
found that 41% of men and 37% of women have experienced 
condom failure, defined as a broken, torn, or slipped-off 
condom. In a subsample of 202 patients who reported condom 
failure, 12% had used oil-based condom lubricants that are 
known to degrade latex, such as hand creams, vaseline, or 
oils. In another separate subsample of 214 patients who had 
experienced condom failure, 7% reported having practised 
dry sex, although we do not know if the dry-sex practices 
were directly associated with condom failure. These rates of 
30 - 40% of persons experiencing condom failure are similar to 
those reported in the US studies cited by Dr Khumalo.2,3 Our 
behavioural surveillance data confirm that condom failure is 
prevalent in at least some high-risk populations in South Africa 
and may be of particular concern in the populations at highest 
risk. The causes of condom failure remain undocumented as 
we found only a minority of cases potentially attributable to 
improper use of lubricants or dry-sex practices. 
As stated by Dr Khumalo, there are interventions that 
reduce condom failure and there are now brief counselling 
interventions that increase condom uptake and proper use in 
STI patients tested in South Africa.4,5 We must also remember 
that condoms succeed in preventing pregnancy, STI and HIV 
infection far more often than they fail. We therefore applaud 
Dr Khumalo’s call for more research as well as evidence-based 
guidelines that include skill-building techniques for improving 
correct and consistent use of condoms.
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Overestimation of the South African 
HIV incidence using the BED IgG 
assay?
To the Editor: We thank Rehle et al. for their important study 
of HIV incidence in South Africa,1 which we read with great 
interest.  We agree with the authors that the incidence of HIV 
in South Africa is probably extremely high, particularly among 
young women, and believe that the study will help us focus 
HIV prevention efforts on appropriate subgroups.  We have 
serious concerns, however, about the applicability of the BED 
IgG assay to the South African HIV epidemic.  In light of recent 
evidence, we are concerned that Rehle et al. have overstated the 
true absolute incidence of HIV in South Africa.
As the name implies, the BED assay was developed using 
sequences from HIV subtypes B, D and E.2  To compensate for 
imperfect sensitivity and specificity, Rehle et al. use a correction 
factor based on McDougal et al.’s study of subtype B virus.3  
Given that the majority of HIV infections considered by Rehle 
et al. were (apparently) of subtype C,1 the applicability of the 
McDougal correction, and indeed of the BED assay itself, to 
these samples is problematic.  More questions arise in light 
of a recent report by Karita et al.4 that the BED assay does not 
perform well in subtype C virus infections; investigators found 
a specificity of 71% (95% confidence interval (CI) 54 - 84%),4 
substantially different from one estimate of specificity used in 
the McDougal correction3 (94% for infections more than 360 
days in the past).  In addition, Karita et al. found that using 
the BED assay with the McDougal correction resulted in 
overestimation of incidence in prospective Ugandan samples 
(subtype not available, but probably A and D5), reporting a 
corrected BED incidence of 6.4% and a true incidence of 1.3 - 
1.7%.4
We are therefore concerned that the incidence figures 
reported by Rehle et al. may be overestimates.  If indeed 
these figures are incorrect, this will make future comparisons 
with more accurate measures of incidence difficult and could 
lead to spurious conclusions with regard to the course of the 
epidemic.  Given these concerns and the current UNAIDS 
recommendation against using the BED assay for incidence 
estimation,6 it would be helpful if the authors clarified their 
findings with a quantitative sensitivity analysis of their 
estimates.  Until the BED assay has been further validated, we 
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